Oliveira E C, Duarte A G E, Boin I F S F, Almeida J R S, Escanhoela C A F
Dept of Pathology, Faculty of Medical Science, Unicamp, São Paulo, Brazil.
Transplant Proc. 2010 Dec;42(10):4116-8. doi: 10.1016/j.transproceed.2010.09.070.
Budd-Chiari syndrome (BCS) in patients progressing to cirrhosis is an indication for liver transplantation. At this stage of disease, it is common to find large benign hepatocellular nodules (LBHNs) of undetermined cause that may be confused with hepatocellular carcinoma (HCC). Patients with indications for liver transplantation are currently classified according to the MELD (Model for End-Stage Liver Disease) severity score. When they fit Barcelona and Milan eligibility criteria for HCC, they receive 20 points. Thus, misdiagnosis of HCC leads to a privileged position on the waiting list. Herein, we have reported three BCS cases of cirrhotic patients who underwent liver transplantation; the pathologic results of their explanted livers showed LBHN. We analyzed three of 489 OLT who had chronic venous outflow obstruction (CVOO) the first case: was a 19-year-old man, with BCS of undetermined cause. The second 20-year-old female patients displayed BCS due to antiphospholipid syndrome the third, 45-year-old man had CVOO diagnosed preliminarily due to cryptogenic cirrhosis in the explanted liver. In the three cases, the nodules in the explant measured 0.5 to 2.4 cm. In the first case, the diagnosis was not in doubt; in the second case, 23 nodules were confused with HCC histologic evaluation, and in the third case three larger hypervascular nodules were misdiagnosed as HCC in the preoperative period despite low alpha-fetoprotein levels. In conclusion it is fundamental to recognize these benign lesions so as to avoid misdiagnosis, thereby allowing the proper selection of candidates for liver transplantation.
布加综合征(BCS)进展为肝硬化的患者是肝移植的适应证。在疾病的这个阶段,常发现原因不明的大型良性肝细胞结节(LBHNs),可能会与肝细胞癌(HCC)混淆。目前,肝移植适应证患者根据终末期肝病模型(MELD)严重程度评分进行分类。当他们符合巴塞罗那和米兰HCC的入选标准时,会获得20分。因此,HCC的误诊会导致在等待名单上处于优先地位。在此,我们报告了3例接受肝移植的肝硬化BCS患者;其切除肝脏的病理结果显示为LBHN。我们分析了489例接受原位肝移植(OLT)且有慢性静脉流出道梗阻(CVOO)的患者中的3例:第一例是一名19岁男性,病因不明的BCS。第二例是一名20岁女性患者,因抗磷脂综合征导致BCS。第三例是一名45岁男性,切除肝脏中因隐源性肝硬化初步诊断为CVOO。在这3例中,切除肝脏中的结节大小为0.5至2.4厘米。第一例诊断明确;第二例中,23个结节在组织学评估中与HCC混淆,第三例中,尽管甲胎蛋白水平较低,但术前3个较大的高血管结节被误诊为HCC。总之,认识这些良性病变以避免误诊至关重要,从而能够正确选择肝移植候选者。